Orthofix launches new bioactive synthetic graft
Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.
Source: beckersspine.com
📰 Tyler Lipschultz News
Tyler Lipschultz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tyler Lipschultz. Real-time updates on events, politics, business and more.
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
12.10.2023 - Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft. Available in both a putty and strip ... Seite 1
Tyler Lipschultz Frank Vizesi Business Wire Chief Scientific Officer Orthofix Global Orthofix Medical Chart
Source: wallstreet-online.de
Orthofix, SeaSpine complete merger
Orthofix and SeaSpine today completed its previously announced merger of equals to create a global spine and orthopedics company.
Source: massdevice.com
SeaSpine® Announces Full Commercial Launch of OsteoTorrent™
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical...
Source: globenewswire.com